Maternal BMI and HDL as predictors of pregnancy outcome in women with type 1 diabetes

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F14%3A10292995" target="_blank" >RIV/00064203:_____/14:10292995 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11130/14:10292995

Výsledek na webu

<a href="http://dx.doi.org/10.3109/14767058.2013.871252" target="_blank" >http://dx.doi.org/10.3109/14767058.2013.871252</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3109/14767058.2013.871252" target="_blank" >10.3109/14767058.2013.871252</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Maternal BMI and HDL as predictors of pregnancy outcome in women with type 1 diabetes

Popis výsledku v původním jazyce

Objective: Diabetes in pregnancy is associated with increased risks of maternal as well as foetal complications. Methods: Retrospective data on 96 women and their 96 newborns were anonymously statistically analysed to assess pregnancies of type 1 diabetes (T1D) women managed in our hospital in past nine years. The outcomes of the neonates were divided into three categories according to the clinical status, presence of congenital abnormalities and infant's treatment. Results: We found out that the outcome of newborn infants associated with maternal HbA1c before gestation as well as during the whole course of pregnancy (p<0.02 for all). Surprisingly, neonatal outcome was strongly associated with the maternal BMI (p<0.05). In our model, a lowering of BMIby one grade led to an 18% increase in the chance that the newborn will have no health problems. We did not observe an important worsening of chronic diabetic complications in mothers; however, regarding maternal clinical status, we found

Název v anglickém jazyce

Maternal BMI and HDL as predictors of pregnancy outcome in women with type 1 diabetes

Popis výsledku anglicky

Objective: Diabetes in pregnancy is associated with increased risks of maternal as well as foetal complications. Methods: Retrospective data on 96 women and their 96 newborns were anonymously statistically analysed to assess pregnancies of type 1 diabetes (T1D) women managed in our hospital in past nine years. The outcomes of the neonates were divided into three categories according to the clinical status, presence of congenital abnormalities and infant's treatment. Results: We found out that the outcome of newborn infants associated with maternal HbA1c before gestation as well as during the whole course of pregnancy (p<0.02 for all). Surprisingly, neonatal outcome was strongly associated with the maternal BMI (p<0.05). In our model, a lowering of BMIby one grade led to an 18% increase in the chance that the newborn will have no health problems. We did not observe an important worsening of chronic diabetic complications in mothers; however, regarding maternal clinical status, we found

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FK - Gynekologie a porodnictví

OECD FORD obor

—

Projekt

<a href="/cs/project/NT11407" target="_blank" >NT11407: Úloha vrozené imunity v rozvoji diabetu 1.typu</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of Maternal-Fetal and Neonatal Medicine

ISSN

1476-7058

e-ISSN

—

Svazek periodika

27

Číslo periodika v rámci svazku

15

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

4

Strana od-do

1580-1583

Kód UT WoS článku

000341928900017

EID výsledku v databázi Scopus

—